Xconomy National

Archives

by in

Entry	Author	Date	Location
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again	Luke Timmerman	10/27/11	Boston
aTyr Pharma Looks to Strike Balance Between Nonprofits, and Really Big For-Profits	Luke Timmerman	07/06/11	San Diego
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News	Erin Kutz	04/01/11	Boston
Vertex CF Drug Shines in Late-Stage Study in Children	Ryan McBride	03/29/11	Boston
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News	Erin Kutz	02/25/11	Boston
Vertex Stock Up 15 Percent on CF Data	Ryan McBride	02/23/11	Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug	Luke Timmerman	02/23/11	Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments	Ryan McBride	01/27/11	Boston
Vertex Raises $443M in Yet Another Monster Stock Sale	Luke Timmerman	12/03/09	Boston
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey	Luke Timmerman	08/07/09	National
Vertex Starts Pivotal CF Trials	Luke Timmerman	05/27/09	Boston
Out With Hedge Funds, In With Blue Bloods: Vertex Transforms Investor Base Via Stock Sale	Luke Timmerman	02/20/09	Boston
Vertex Raises $320M in Secondary Stock Offering	Luke Timmerman	02/19/09	Boston
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days	Luke Timmerman	10/20/08	Boston
Vertex Marching Ahead With Cystic Fibrosis Program	Luke Timmerman	08/01/08	Boston
Page 1 of 1